Back to Investor Brief

Investor Brief · Part 2

Competition: the landscape and where we win

The menopause space is crowded on the patient side and empty on the provider side. Pause-Health.ai claims the provider/payer category before incumbents can pivot in.

Landscape

DTC menopause brands

Midi Health, Evernow, Alloy, Winona, Versalie

  • Primary audiencePatients directly (subscription telehealth + RX)
  • StrengthBrand recognition and patient demand. Beautiful consumer UX. Have de-stigmatized menopause conversations.
  • WeaknessCash-pay or limited insurance; capture only the ~10% of women willing to pay out-of-pocket. No integration with the patient's actual longitudinal record.
  • Overlap with PauseLow — different buyer, different funding source

Employer-benefits platforms

Maven Clinic, Carrot, Progyny, Kindbody

  • Primary audienceSelf-insured employers, increasingly carrying menopause
  • StrengthStrong distribution into Fortune 500. Comprehensive women's health benefits across fertility, maternity, menopause.
  • WeaknessMenopause is one of many lines; not the focus. Most rely on a network of contracted clinicians rather than augmenting the patient's existing provider.
  • Overlap with PauseMedium — we could plug INTO these platforms as the clinical decision layer rather than competing on benefits brand

Specialty menopause clinics

Independent NAMS-certified practices, hospital midlife clinics

  • Primary audiencePatients with means and motivation to seek out a specialist
  • StrengthDeep expertise. Trusted relationships. Often early adopters of new tooling.
  • WeaknessCapacity-limited; thousands exist, but cannot scale to the ~50M women who need this care.
  • Overlap with PauseLow — they are buyers, not competitors. Pause amplifies their reach into general OB/GYN and primary care.

EHR-embedded clinical AI

Abridge, Suki, DeepScribe, Nuance DAX

  • Primary audienceHealth systems, broadly
  • StrengthStrong EHR integration story. Documented productivity wins.
  • WeaknessHorizontal: scribes and notes, not condition-specific clinical reasoning. Not a menopause product.
  • Overlap with PauseAdjacent — coexists. We integrate into the same EHRs but solve a different problem (clinical reasoning, not transcription).

Disease-specific clinical AI

Cleerly (cardiology), K Health (primary care), Aidoc (radiology)

  • Primary audienceHealth systems and specialty service lines
  • StrengthProves the model: vertical AI products that win because they go deep into one condition.
  • WeaknessNone are focused on menopause — the category leader is open.
  • Overlap with PauseValidating precedent — establishes the buying motion for condition-specific provider AI.

Generalist LLM offerings

Foundation-model providers selling 'healthcare' SKUs

  • Primary audienceHealth systems experimenting
  • StrengthPowerful base models. Cheap experimentation surface.
  • WeaknessNo menopause-specific grounding, no clinical workflow, no evidence base, no integration. Pilots stall.
  • Overlap with PauseLow — they're a substrate, not a competitor. We build on top of best-in-class foundation models.

Capability matrix

CapabilityPause-Health.aiDTC menopauseEmployer benefitsEHR clinical AIGeneralist LLM
Menopause clinical depthYes — purpose-builtLimited — visit-levelPartial — multi-lineNoNo
EHR-integrated (FHIR / SMART)YesNoNoYesNo
Wearable + PRO integrationYesPartialPartialNoNo
Explainable, evidence-grounded recommendationsYes — guideline retrievalNoNoPartialNo
Sold to providers + payers (not patients)YesNoEmployer-paidYesVariable
Outcomes telemetry / continuous learningYesLimitedLimitedLimitedNo

Why we win